[Journal logo]

Volume 67 
Part 1 
Page o154  
January 2011  

Received 15 November 2010
Accepted 13 December 2010
Online 18 December 2010

Key indicators
Single-crystal X-ray study
T = 423 K
Mean [sigma](C-C) = 0.006 Å
R = 0.052
wR = 0.142
Data-to-parameter ratio = 15.2
Details
Open access

3-{[5-(4-Bromophenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]methyl}-1,2-benzoxazole

aDepartment of Studies in Chemistry, Bangalore University, Bangalore 560 001, India, and bDepartment of Chemistry, Karnatak University, Dharwad 580 003, India
Correspondence e-mail: noorsb@rediffmail.com

In the title compound, C18H11BrN4OS, the imidazothiadiazole and benzisoxazole rings are individually planar with maximum deviations of 0.025 (3) 0.015 (4) Å, respectively, and are inclined at an angle of 23.51 (7)° with respect to each other. The planes of the imidazothiadiazole and bromophenyl rings are inclined at an angle of 27.34 (3)°. In the crystal, intermolecular C-H...N interactions result in chains of molecules along the b and c axes. Moreover, C-H...O interactions result in centrosymmetric head-to-head dimers with R22(24) graph-set motifs. The molecular packing is further stabilized by [pi]-[pi] stacking interactions between the imidazole rings with a shortest centroid-centroid distance of 3.492 (3) Å. In addition, C-H...[pi] interactions are observed in the crystal structure.

Related literature

For the biological activity of benzisoxazole derivatives, see: Priya et al. (2005[Priya, B. S., Basappa., Swamy, S. N., Rangappa, K. S. (2005). Bioorg. Med. Chem. 13, 2623-2628.]). For the preparation of the title compound, see: Lamani et al. (2009[Lamani, R. S., Shetty, N. S., Ravindra, R. & Khazi, I. A. M. (2009). Eur. J. Med. Chem. 44, 2828-2833.]). For a related structure, see: Sun & Zhang (2009[Sun, Y. & Zhang, H.-H. (2009). Acta Cryst. E65, o1647.]). For graph-set notation, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]).

[Scheme 1]

Experimental

Crystal data
  • C18H11BrN4OS

  • Mr = 411.28

  • Monoclinic, C 2/c

  • a = 38.985 (17) Å

  • b = 5.764 (3) Å

  • c = 14.925 (6) Å

  • [beta] = 109.191 (13)°

  • V = 3167 (2) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 2.74 mm-1

  • T = 423 K

  • 0.18 × 0.16 × 0.16 mm

Data collection
  • Bruker SMART APEX CCD detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 1998[Bruker. (1998). SMART, SAINT-Plus and SADABS. Bruker Axs Inc., Madison, Wisconcin, USA.]) Tmin = 0.638, Tmax = 0.668

  • 8879 measured reflections

  • 3432 independent reflections

  • 2534 reflections with I > 2[sigma](I)

  • Rint = 0.081

Refinement
  • R[F2 > 2[sigma](F2)] = 0.052

  • wR(F2) = 0.142

  • S = 1.02

  • 3432 reflections

  • 226 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 1.10 e Å-3

  • [Delta][rho]min = -1.02 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg4 and Cg5 are the centroids of the C1-C6 and C13-C18 rings, respectively.

D-H...A D-H H...A D...A D-H...A
C2-H2...O1i 0.93 2.38 3.219 (6) 150
C8-H8...N1ii 0.93 2.60 3.469 (6) 156
C11-H11B...N1iii 0.97 2.48 3.358 (6) 150
C4-H4...Cg5iii 0.93 2.96 3.554 (5) 123
C18-H18...Cg4iii 0.93 2.83 3.496 (5) 130
Symmetry codes: (i) [-x+{\script{1\over 2}}, -y+{\script{1\over 2}}, -z+1]; (ii) x, y+1, z; (iii) [-x+{\script{1\over 2}}, y+{\script{1\over 2}}, -z+{\script{1\over 2}}].

Data collection: SMART (Bruker, 1998[Bruker. (1998). SMART, SAINT-Plus and SADABS. Bruker Axs Inc., Madison, Wisconcin, USA.]); cell refinement: SAINT-Plus (Bruker, 1998[Bruker. (1998). SMART, SAINT-Plus and SADABS. Bruker Axs Inc., Madison, Wisconcin, USA.]); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and CAMERON (Watkin et al., 1996)[Watkin, D. J., Prout, C. K. & Pearce, L. J. (1996). CAMERON. Chemical Crystallography Laboratory, University of Oxford, England.]; software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: PV2359 ).


Acknowledgements

NSB is thankful to the University Grants Commission (UGC), India, for financial assistance and the Department of Science and Technology, (DST), India, for the data collection facility under the IRHPA-DST program.

References

Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.  [CrossRef] [ChemPort] [ISI]
Bruker. (1998). SMART, SAINT-Plus and SADABS. Bruker Axs Inc., Madison, Wisconcin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Lamani, R. S., Shetty, N. S., Ravindra, R. & Khazi, I. A. M. (2009). Eur. J. Med. Chem. 44, 2828-2833.  [CrossRef] [PubMed] [ChemPort]
Priya, B. S., Basappa., Swamy, S. N., Rangappa, K. S. (2005). Bioorg. Med. Chem. 13, 2623-2628.  [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Sun, Y. & Zhang, H.-H. (2009). Acta Cryst. E65, o1647.  [CSD] [CrossRef] [details]
Watkin, D. J., Prout, C. K. & Pearce, L. J. (1996). CAMERON. Chemical Crystallography Laboratory, University of Oxford, England.


Acta Cryst (2011). E67, o154  [ doi:10.1107/S1600536810052232 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.